Click here for important risk information.

The First & Only FDA-Approved Liquid Dronabinol

SYNDROS is the first FDA-approved cannabinoid used to treat:

  • The loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight
  • Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea medicines

What Is SYNDROS

Treatment for
Breakthrough CINV

SYNDROS is liquid dronabinol containing a cannabinoid indicated for chemotherapy-induced nausea and vomiting (CINV) in people whose nausea and vomiting have not improved with usual anti-nausea medicines.

Learn More About CINV & SYNDROS

test

test

Appetite Stimulation for AIDS-related Weight Loss

SYNDROS is liquid dronabinol containing a cannabinoid also indicated for loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight.

Learn more about SYNDROS for appetite stimulation

test

Today, you can start saving on your medical expenses by signing up for the SYNDROS Co-Pay Savings Card program. This program can offer you free product and up to $400 off of each new prescription bottle of SYNDROS oral dronabinol solution.

 

Explore Your Options

Is Liquid Dronabinol for You?

Patients with chronic diseases such as cancer and AIDS may benefit from a liquid formulation of dronabinol tetrahydrocannabinol (THC) therapy. A dronabinol oral solution like SYNDROS may be a fit for you if:

  • You prefer a liquid medication
  • Your physician prefers liquid titration and delivery for flexible dosage

Chemotherapy-Induced Nausea and Vomiting (CINV)

Many patients on antiemetics still experience nausea and vomiting while receiving chemotherapy. SYNDROS was developed for cancer patients who experience nausea and vomiting while undergoing chemotherapy treatment and who have not responded well to conventional antiemetic treatments.

 

Explore In Depth

 

 


Anorexia Associated with Weight Loss in Patients with AIDS

Approximately 90,000 patients in the United States with HIV/AIDS may experience weight loss, including weight loss due to anorexia. SYNDROS is also indicated for patients who want to counteract weight loss and anorexia associated with AIDS.  

 

Explore In Depth

Do Not Take SYNDROS If You:

Had an allergic reaction to dronabinol. Signs and symptoms of an allergic reaction to dronabinol include: swelling of the lips, hives, a rash over your whole body, mouth sores, skin burning, flushing and throat tightness.

Had an allergic reaction to alcohol.

Are using a medicine that contains disulfiram (Antabuse) or metronidazole (Pylera, Flagyl, Flagyl ER, Nuvessa, Vandazole) or have taken or received a medicine that contains disulfiram or metronidazole in the last 14 days.

Patient Support Services

Our patient support program, SYNDROS CaresTM, is designed with patients in mind. This zero dollar, out-of-pocket co-pay arrangement revolves around complimentary, convenient and comprehensive services. Enroll today for individualized outreach and have SYNDROS delivered straight to your door.

 

Explore More